State of Wyoming’s Zentalis Pharmaceuticals ZNTL Stock Holding History

State of Wyoming’s Portfolio ZNTL Stock Details ZNTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$66.6K	Buy	+28,466	New	+$73.5K	0.01%	1434
2025 Q3	–	Sell	-73,797	Closed	-$85.6K	–	2092
2025 Q2	$85.6K	Buy	73,797 +28,621	+63%	+$37.7K	0.01%	1360
2025 Q1	$71.8K	Buy	45,176 +10,460	+30%	+$22.6K	0.01%	1313
2024 Q4	$105K	Buy	34,716 +19,262	+125%	+$63.1K	0.01%	1158
2024 Q3	$56.9K	Buy	+15,454	New	+$56.2K	0.01%	1378
2021 Q4	–	Sell	-83	Closed	-$6K	–	1999
2021 Q3	$6K	Sell	83 -597	-88%	-$34.4K	﹤0.01%	1081
2021 Q2	$36K	Buy	680 +387	+132%	+$20.7K	0.02%	826
2021 Q1	$13K	Buy	+293	New	+$12.6K	0.02%	368

Other funds holding ZNTL

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $273M AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

State of Wyoming's ZNTL Position: Q1 2026 in Review

State of Wyoming opened a new position in Zentalis Pharmaceuticals (ZNTL) in Q1 2026: 28,466 shares worth $66.6K. The stake represents 0.01% of the portfolio and ranks #1434 among its holdings. This is a return to the name: State of Wyoming previously reported a position in ZNTL as recently as Q2 2025.

State of Wyoming first reported a position in ZNTL in Q1 2021 and has held it in 8 quarters since. The position peaked at $105K in Q4 2024. 102 funds tracked by Wall St. Rank hold ZNTL as of Q1 2026.

State of Wyoming held 28,466 shares of Zentalis Pharmaceuticals worth $66.6K as of Q1 2026.
Zentalis Pharmaceuticals was a new State of Wyoming position in Q1 2026.
Zentalis Pharmaceuticals made up 0.01% of State of Wyoming's portfolio in Q1 2026, its #1434 holding.
State of Wyoming first reported a position in Zentalis Pharmaceuticals in Q1 2021 and has held it in 8 quarters since.
State of Wyoming's Zentalis Pharmaceuticals position peaked at $105K in Q4 2024.
102 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.